Résumés
Résumé
Classiquement, les fibroses cutanées sont considérées comme l’étape ultime d’un processus inflammatoire chronique et persistant, qui pérennise l’hyperplasie et la différenciation fibroblastique ainsi que l’accumulation de matrice extracellulaire. Le retentissement clinique de ces fibroses s’exprime tant au niveau esthétique que fonctionnel, et se révèle d’autant plus problématique qu’il n’existe à ce jour ni régression spontanée, ni thérapeutique antifibrosante efficace et sûre. Le développement et le maintien de la fibrose cutanée impliquent les différents composants cellulaires de la peau ainsi que plusieurs médiateurs paracrines, qui activent différentes voies de signalisation intracellulaires : ce réseau d’interaction est complexe et difficile à modéliser. Cette revue présente les modèles cellulaires et expérimentaux permettant de modéliser la fibrose cutanée, et expose leurs apports dans la compréhension des mécanismes physiopathologiques de fibrogenèse cutanée. Ces modèles constituent des outils performants pour tester de nouvelles hypothèses mécanistiques et thérapeutiques.
Summary
Skin fibrosis is classically seen as the consequence of chronic inflammation and altered healing response that is characterized by the differentiation of fibroblasts into secretory myofibroblasts and accumulation of connective tissue. Although fibrosis severely affects organ function and causes esthetic defects, no effective therapy is currently available to attenuate the fibrogenic process probably because the fibrogenic process is more complex than previously thought. Indeed, it might involve several interacting and mutually dependent cell types (fibroblasts, keratinocytes, endothelial cells, inflammatory cells), numerous paracrine factors, bio-active molecules and micro-environmental stimuli (growth factors, vasoactive peptides, balance between pro- and anti-inflammatory cytokines, coagulation system, reactive oxygen species, extracellular matrix…). In this perspective, the traditional approach that model individual cell response in simple cell culture system is probably inadequate and too simplistic. This article reviews the new models used to study skin fibrosis in vitro, in organotypic culture systems and in vivo and examines how these different models might be used to identify new molecular pathways involved in fibrogenesis. The monolayer cultures allow the study of fibrogenic signals induced by a single factor on a single cell type. Isolation of cells from fibrotic tissue allows to define the fibrogenic differentiation acquired in vivo. The organotypic models allow cell to cell and cell to matrix interaction and the experimental models in pigs and mice allowed studies in integrated physiological systems. These various and complementary models would also provide new tools to develop and test new drugs and treatments.
Parties annexes
Références
- 1. Sivan V, Vozenin-Brotons MC, Tricaud Y, et al. Altered proliferation and differentiation of human epidermis in cases of skin fibrosis after radiotherapy. Int J Radiat Oncol Biol Phys 2002 ; 53 : 385-93.
- 2. Miliani de Marval PL, Gimenez-Conti IB, LaCava M, et al. Transgenic expression of cyclin-dependent kinase 4 results in epidermal hyperplasia, hypertrophy, and severe dermal fibrosis. Am J Pathol 2001 ; 159 : 369-79.
- 3. Archambeau JO, Pezner R, Wasserman T. Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys 1995 ; 31 : 1171-85.
- 4. Tomasek JJ, Gabbiani G, Hinz B, et al. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002 ; 3 : 349-63.
- 5. Hinz B, Gabbiani G. Mechanisms of force generation and transmission by myofibroblasts. Curr Opin Biotechnol 2003 ; 14 : 538-46.
- 6. Martin M, Lefaix J, Delanian S. TGF-beta1 and radiation fibrosis : a master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys 2000 ; 47 : 277-90.
- 7. Serini G, Bochaton-Piallat ML, Ropraz P, et al. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 1998 ; 142 : 873-81.
- 8. Verrecchia F, Mauviel A. Control of connective tissue gene expression by TGF beta : role of Smad proteins in fibrosis. Curr Rheumatol Rep2002 ; 4 : 143-9.
- 9. Verrecchia F, Mauviel A. Transforming growth factor-beta signaling through the Smad pathway : role in extracellular matrix gene expression and regulation. J Invest Dermatol 2002 ; 118 : 211-5.
- 10. Grotendorst GR, Rahmanie H, Duncan MR. Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J 2004 ; 18 : 469-79.
- 11. Reisdorf P, Lawrence DA, Sivan V, et al. Alteration of transforming growth factor-beta1 response involves down-regulation of Smad3 signaling in myofibroblasts from skin fibrosis. Am J Pathol 2001 ; 159 : 263-72.
- 12. Gore-Hyer E, Pannu J, Smith EA, et al. Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts. Arthritis Rheum 2003 ; 48 : 798-806.
- 13. Leask A, Abraham DJ. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol 2003 ; 81 : 355-63.
- 14. Holmes A, Abraham DJ, Chen Y, et al. Constitutive CTGF expression in scleroderma fibroblasts is dependent on Sp1. J Biol Chem 2003 ; 29 : 29.
- 15. Grinnell F. Fibroblast-collagen-matrix contraction : growth-factor signalling and mechanical loading. Trends Cell Biol 2000 ; 10 : 362-5.
- 16. Lee DJ, Ho CH, Grinnell F. LPA-stimulated fibroblast contraction of floating collagen matrices does not require Rho kinase activity or retraction of fibroblast extensions. Exp Cell Res 2003 ; 289 : 86-94.
- 17. Finesmith TH, Broadley KN, Davidson JM. Fibroblasts from wounds of different stages of repair vary in their ability to contract a collagen gel in response to growth factors. J Cell Physiol 1990 ; 144 : 99-107.
- 18. Bellemare J, Roberge CJ, Bergeron D, et al. Epidermis promotes dermal fibrosis : role in the pathogenesis of hypertrophic scars. J Pathol 2005 ; 206 : 1-8.
- 19. Vozenin-Brotons MC, Sivan V, Gault N, et al. Antifibrotic action of Cu/Zn SOD is mediated by TGF-beta1 repression and phenotypic reversion of myofibroblasts. Free Radic Biol Med 2001 ; 30 : 30-42.
- 20. Lefaix JL, Daburon F. Diagnosis of acute localized irradiation lesions : review of the French experimental experience. Health Phys 1998 ; 75 : 375-84.
- 21. Flanders KC, Sullivan CD, Fujii M, et al. Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am J Pathol 2002 ; 160 : 1057-68.
- 22. Lakos G, Takagawa S, Chen SJ, et al. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am J Pathol 2004 ; 165 : 203-17.
- 23. Xu J, Benyon RC, Leir SH, et al. Matrix metalloproteinase-2 from bronchial epithelial cells induces the proliferation of subepithelial fibroblasts. Clin Exp Allergy 2002 ; 32 : 881-8.
- 24. Haston CK, Zhou X, Gumbiner-Russo L, et al. Universal and radiation-specific loci influence murine susceptibility to radiation-induced pulmonary fibrosis. Cancer Res 2002 ; 62 : 3782-8.
- 25. Nakao A, Fujii M, Matsumura R, et al. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 1999 ; 104 : 5-11.